XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.3

Warrants (Tables)

9 Months Ended

Sep. 30, 2025

Warrants

Schedule of warrant activity

Schedule of warrant activity
		Warrants				Weighted-Average Remaining Contractual Life				Weighted-Average Exercise Price per Share
Outstanding at December 31, 2024			25,734,752				1.16			$	2.19
Granted			–				–				–
Exercised			(1,462,000	)			–				0.01
Expired			(121,809	)			–				3.60
Forfeitures			–				–				–
Outstanding at September 30, 2025			24,150,943				2.85			$	2.32
Exercisable at September 30, 2025			24,150,943				2.85			$	2.32

Schedule of assumptions

Schedule of assumptions
		May 13, 2025
Market Price		$0.65
Exercise Price		$0.57
Dividend Yield		–%
Volatility		86.3%
Risk-free Interest Rate		4.1%
Expected Life of Warrants		5.00

The fair value of the outstanding Series A derivative warrants was determined by using the BSM option pricing model based on the following assumptions as of December 31, 2024:

		December 31, 2024
Market Price		$0.59
Exercise Price		$0.57
Dividend Yield		–%
Volatility		101.6%
Risk-free Interest Rate		4.0%
Expected Life of Warrants		5.00

The fair value of the outstanding Series B derivative warrants, prior to their reclassification to equity, was determined by using the BSM option pricing model based on the following assumptions as of May 13, 2025:

		May 13, 2025
Market Price		$0.65
Exercise Price		$0.57
Dividend Yield		–%
Volatility		68.9%
Risk-free Interest Rate		4.1%
Expected Life of Warrants		1.50

The fair value of the outstanding Series B derivative warrants was determined by using the BSM option pricing model based on the following assumptions as of December 31, 2024:

		December 31, 2024
Market Price		$0.59
Exercise Price		$0.57
Dividend Yield		–%
Volatility		82.5%
Risk-free Interest Rate		4.0%
Expected Life of Warrants		1.50

X

- References

No definition available.

+ Details

Name:	TOON_DisclosureWarrantsAbstract
Namespace Prefix:	TOON_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the activity in the balance of servicing liabilities subsequently measured at fair value (including a description of where changes in fair value are reported in the statement of income for each period for which results of operations are presented), including but not limited to, the following: beginning and ending balances, additions (through assumptions of servicing obligations, and servicing obligations that result from transfers of financial assets), disposals, changes in fair value during the period resulting from changes in inputs or assumptions used in the valuation model, other changes in fair value and a description of those changes, and other changes that affect the balance and a description of those changes.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 860
-SubTopic 50
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481229/860-50-50-3

+ Details

Name:	us-gaap_ScheduleOfServicingLiabilitiesAtFairValueTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration